[ad_1]
Following FDA emergency approval, CDC recommendation decision … Delivery starts tomorrow and arrives around the corner early next week
The world’s largest ‘crown den’ begins inoculating high-risk groups like medical workers in the US.
The first new vaccination against coronavirus infection (Corona 19) in the United States is expected to begin next week.
Given that the vaccine is distributed in the United States, the world’s largest corona19 victim, it is noteworthy if it can serve as a ‘game changer’ to catch the global pandemic.
The advisory committee of the US Centers for Disease Control and Prevention (CDC) held a meeting on the 12th (local time) and decided to recommend the use of the COVID-19 vaccine jointly developed by Pfizer and Bioentech.
With the approval of CDC Director Robert Redfield, all administrative procedures for Pfizer vaccines are finalized.
The day before, the Food and Drug Administration (FDA) made the decision to approve emergency use.
The opening of the vaccination route in the United States, where the number of confirmed corona19 and deaths in the world is higher, is expected to be a milestone in the war against the pandemic (a global pandemic of infectious diseases).
FDA Director Stephen Han said today at a press conference that it is a “significant milestone in the response to the devastating pandemic that has affected countless families in the United States and around the world.”
According to the Johns Hopkins University of the United States, at 2:30 p.m. on the day, the cumulative confirmed cases of corona 19 in the United States were 1,596 to 6,496, and deaths were 29,6,795, all of which have no rival in the world.
Recently, in winter, 200,000 confirmed cases and 3,000 deaths per day are spreading uncontrollably, creating fear again.
In this situation, Pfizer, an American pharmaceutical company in partnership with German Bioentech, managed to develop a vaccine with a 95% preventive effect in less than a year, which is assessed as a great achievement.
After that, the American biotech company Modena will develop a vaccine with similar efficacy and will soon receive approval for emergency use.
It was also the basis that the US administration of Donald Trump launched a joint “Operation Warp Speed” with public and private forces in April and provided $ 12 billion for vaccine development alone.
Because the current situation is so dire, manufacturers and related authorities are embarking on an emergency operation to deliver the first 2.9 million doses of vaccine to the country without delay.
Starting the morning of the 13th, the day after the recommendation of the CDC Advisory Committee, vaccine delivery begins at the Pfizer factory in Calamer, Michigan, and is transferred to logistics centers in the United States by truck and plane. .
Dry ice and special containers are mobilized for Pfizer vaccines that must be stored at -70 degrees Celsius, and logistics companies FedEx and UPS connect special devices that can check the location and temperature in real time on all transport trucks of vaccinations
The high-speed operations team said the initial vaccine supply will reach 636 delivery destinations across the country from the morning of 14-16.
Distribution is completed in three weeks at local pharmacies and state government designated vaccination facilities.
Pfizer plans to supply up to 25 million doses of vaccine in the United States by the end of the year.
Additionally, the company said it will be able to supply 20 million doses during the year if the FDA and CDC approve modders and vaccines.
The supply of vaccines in the US will begin in earnest next year.
Health and Welfare Minister Alix Aza said in an interview with CNN that the United States has signed a contract to buy vaccines for up to 3 billion doses from six global pharmaceutical companies, including Pfizer and Modena.
According to the Wall Street Journal (WSJ), an estimated 21 million people in the medical industry, who are the priority targets for urgent vaccination, and 3 million people live in long-term care facilities.
After these, 87 million workers in essential industries in the non-medical sector are expected to receive the vaccine first.
If proceeded smoothly, experts predicted that after next summer, more than 70% of the population will have immunity to Corona 19, thus achieving the group immunity they hoped for.
The obstacle is negative public opinion about vaccines.
Over the course of last month’s presidential elections, the COVID-19 quarantine measures became a political issue, and there are many Americans who are reluctant to the vaccine itself.
The Associated Press and the University of Chicago Public Opinion Research Center (NORC) surveyed 1,117 adult men and women in the US 3-7. Answered.
/ yunhap news
